Question 3: This was a development of the dried plasma used to treat the wounded during ________ and variants on the process are still used to make a variety of other medications.
Question 5: Since the anticoagulant is returned to the donor along with blood components that are not being collected, it can bind the ________ in the donor's blood and cause hypocalcemia.
Question 7: The collecting agency usually identifies whether the blood is type A, B, AB, or O and the donor's Rh (D) type and will screen for ________ to less common antigens.
Question 8: The subject was discussed at length after the ________ in the United States, and the consensus was that collecting during a disaster was impractical and that efforts should be focused on maintaining an adequate supply at all times.